Track topics on Twitter Track topics that are important to you
The FDA has granted Myoscience 510(k) clearance for its Iovera device, a nonopioid and nonsystemic treatment for providing re -More-
The US Food & Drug Administration (FDA) has approved new indication for Myoscience's ioveraÂ° device to relieve pain and symptoms associated with osteoarthritis of the knee.
Life Sciences Jobs ...
The iovera technology from Myoscience, Inc, is a nonopioid, nonsystemic treatment for blocking pain signals from peripheral nerves in patients with knee osteoarthritis (OA). FDA Approvals
A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's...
We have published hundreds of MyoScience, Inc. news stories on BioPortfolio along with dozens of MyoScience, Inc. Clinical Trials and PubMed Articles about MyoScience, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MyoScience, Inc. Companies in our database. You can also find out about relevant MyoScience, Inc. Drugs and Medications on this site too.